• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β链57位残基对HLA-DR和-DQ分子肽结合能力的关键作用。

Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

作者信息

Nepom B S, Nepom G T, Coleman M, Kwok W W

机构信息

The Virgina Mason Research Center, University of Washington School of Medicine, Seattle, WA 98110, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7202-6. doi: 10.1073/pnas.93.14.7202.

DOI:10.1073/pnas.93.14.7202
PMID:8692969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC38960/
Abstract

Position 57 in the beta chain of HLA class II molecules maintains an Asp/non-Asp dimorphism that has been conserved through evolution and is implicated in susceptibility to some autoimmune diseases. The latter effect may be due to the influence of this residue on the ability of class II alleles to bind specific pathogenic peptides. We utilized highly homologous pairs of both DR and DQ alleles that varied at residue 57 to investigate the impact of this dimorphism on binding of model peptides. Using a direct binding assay of biotinylated peptides on whole cells expressing the desired alleles, we report several peptides that bind differentially to the allele pairs depending on the presence or absence of Asp at position 57. Peptides with negatively charged residues at anchor position 9 bind well to alleles not containing Asp at position 57 in the beta chain but cannot bind well to homologous Asp-positive alleles. By changing the peptides at the single residue predicted to interact with this position 57, we demonstrate a drastically altered or reversed pattern of binding. Ala analog peptides confirm these interactions and identify a limited set of interaction sites between the bound peptides and the class II molecules. Clarification of the impact of specific class II polymorphisms on generating unique allele-specific peptide binding "repertoires" will aid in our understanding of the development of specific immune responses and HLA-associated diseases.

摘要

人类白细胞抗原II类分子β链中的第57位氨基酸存在天冬氨酸/非天冬氨酸二态性,这种二态性在进化过程中得以保留,并与某些自身免疫性疾病的易感性有关。后一种效应可能是由于该残基对II类等位基因结合特定致病肽能力的影响。我们利用DR和DQ等位基因的高度同源对,这些等位基因在第57位氨基酸上有所不同,以研究这种二态性对模型肽结合的影响。通过对表达所需等位基因的全细胞进行生物素化肽的直接结合测定,我们报告了几种肽,它们根据第57位是否存在天冬氨酸而与等位基因对有不同的结合。在第9位锚定位置带有负电荷残基的肽能很好地结合β链中第57位不含有天冬氨酸的等位基因,但不能很好地结合同源的天冬氨酸阳性等位基因。通过改变预测与第57位相互作用的单个残基处的肽,我们证明了结合模式发生了急剧改变或逆转。丙氨酸类似肽证实了这些相互作用,并确定了结合肽与II类分子之间有限的一组相互作用位点。阐明特定II类多态性对产生独特的等位基因特异性肽结合“库”的影响,将有助于我们理解特异性免疫反应和HLA相关疾病的发展。

相似文献

1
Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.β链57位残基对HLA-DR和-DQ分子肽结合能力的关键作用。
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7202-6. doi: 10.1073/pnas.93.14.7202.
2
The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.HLA-DQ2(非天冬氨酸β57)的P9口袋对在其他1型糖尿病易感非天冬氨酸β57 MHC II类分子中发现的带负电荷的锚定残基没有特别偏好。
Int Immunol. 1998 Aug;10(8):1229-36. doi: 10.1093/intimm/10.8.1229.
3
HLA-DQB1 codon 57 is critical for peptide binding and recognition.人类白细胞抗原-DQB1第57密码子对于肽结合和识别至关重要。
J Exp Med. 1996 Mar 1;183(3):1253-8. doi: 10.1084/jem.183.3.1253.
4
HLA-DQ polymorphisms are highly selective for peptide binding interactions.人类白细胞抗原-DQ多态性对肽结合相互作用具有高度选择性。
J Immunol. 1995 Sep 1;155(5):2468-76.
5
Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia.HLA-DQβ基因第57位密码子的天冬氨酸纯合性与柬埔寨人群肺结核易感性相关。
J Immunol. 2006 Jan 15;176(2):1090-7. doi: 10.4049/jimmunol.176.2.1090.
6
Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.不同的肽相互作用模式使HLA - DQ和HLA - DR分子能够结合多种肽库。
J Immunol. 1997 Jul 15;159(2):703-11.
7
Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.来自两个与疾病抗性相关的HLA-DR13等位基因的天然加工肽显示出相关的序列基序以及HLA-DRβ链第86位二态性的影响。
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6567-71. doi: 10.1073/pnas.92.14.6567.
8
A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.一种新模型定义了HLA-DQ和-DR中多态性的最小集合,该集合决定了对自身免疫性糖尿病的易感性和抗性。
Biol Direct. 2008 Oct 14;3:42. doi: 10.1186/1745-6150-3-42.
9
Peptide binding predictions for HLA DR, DP and DQ molecules.HLA-DR、DP 和 DQ 分子的肽结合预测。
BMC Bioinformatics. 2010 Nov 22;11:568. doi: 10.1186/1471-2105-11-568.
10
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).利用洗脱肽序列数据鉴定肽与胰岛素依赖型糖尿病易感等位基因HLA - DQ8(DQ 3.2)的结合特性。
Int Immunol. 1997 Jun;9(6):905-11. doi: 10.1093/intimm/9.6.905.

引用本文的文献

1
Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.基于质谱的人白细胞抗原蛋白呈递肽免疫肽组学
Methods Mol Biol. 2024;2758:425-443. doi: 10.1007/978-1-0716-3646-6_23.
2
T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen.T 细胞自身免疫与免疫调节针对桥粒芯糖蛋白 3,天疱疮自身抗原。
J Dermatol. 2023 Feb;50(2):112-123. doi: 10.1111/1346-8138.16663. Epub 2022 Dec 20.
3
Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data.免疫肽组学工具包库 (IPTK):一个基于 Python 的模块化工具包,用于分析免疫肽组学数据。
BMC Bioinformatics. 2021 Aug 17;22(1):405. doi: 10.1186/s12859-021-04315-0.
4
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.一项评估结直肠癌肝转移射频消融后免疫反应的非介入性临床试验。
Front Immunol. 2019 Nov 19;10:2526. doi: 10.3389/fimmu.2019.02526. eCollection 2019.
5
Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.基于质谱的 MHC 结合肽鉴定用于免疫肽组学。
Nat Protoc. 2019 Jun;14(6):1687-1707. doi: 10.1038/s41596-019-0133-y. Epub 2019 May 15.
6
Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.抗原靶向人类HLA II类分子可提高DNA疫苗接种的效果。
J Immunol. 2016 Nov 1;197(9):3575-3585. doi: 10.4049/jimmunol.1600893. Epub 2016 Sep 26.
7
ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study.1型糖尿病遗传学联盟研究中ATPase4A自身反应性及其与自身免疫表型的关联。
Diabetes Care. 2015 Oct;38 Suppl 2(Suppl 2):S29-36. doi: 10.2337/dcs15-2006.
8
Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations.在亚洲和欧洲人群中,抗环瓜氨酸肽抗体(ACPA)阳性类风湿性关节炎的风险是由共享的人类白细胞抗原(HLA)氨基酸多态性驱动的。
Hum Mol Genet. 2014 Dec 20;23(25):6916-26. doi: 10.1093/hmg/ddu387. Epub 2014 Jul 28.
9
Multiple HLA epitopes contribute to type 1 diabetes susceptibility.多种 HLA 表位导致 1 型糖尿病易感性。
Diabetes. 2014 Jan;63(1):323-31. doi: 10.2337/db13-1153.
10
Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.DRB1*08:01 和 DRB1*11:01 通过其结构基序预测丙酮酸脱氢酶复合体-E2 表位的差异结合,并与疾病风险相关。
J Immunol. 2013 May 1;190(9):4516-24. doi: 10.4049/jimmunol.1202445. Epub 2013 Mar 29.

本文引用的文献

1
Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.来自四个HLA-DR等位基因的自身肽在氨基末端附近共享疏水锚定残基,包括脯氨酸作为修剪的终止信号。
J Immunol. 1993 Nov 1;151(9):4732-42.
2
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.HLA-DR结合肽中的混杂性和等位基因特异性锚定残基
Cell. 1993 Jul 16;74(1):197-203. doi: 10.1016/0092-8674(93)90306-b.
3
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.人类II类组织相容性抗原HLA - DR1的三维结构。
Nature. 1993 Jul 1;364(6432):33-9. doi: 10.1038/364033a0.
4
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.与HLA - DR等位基因结合的天然加工肽之间的特异性和混杂性。
J Exp Med. 1993 Jul 1;178(1):27-47. doi: 10.1084/jem.178.1.27.
5
Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.通过混合测序鉴定HLA-DQ2肽结合基序和HLA-DPw3结合的自身肽。
Eur J Immunol. 1994 Feb;24(2):375-9. doi: 10.1002/eji.1830240216.
6
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule.
Int Immunol. 1994 Mar;6(3):453-61. doi: 10.1093/intimm/6.3.453.
7
High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.通过锚定组合实现短肽与主要组织相容性复合体II类分子的高亲和力结合。
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4456-60. doi: 10.1073/pnas.91.10.4456.
8
Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.HLA-DR分子中多态性残基在肽配体等位基因特异性结合中的作用。
J Immunol. 1994 May 15;152(10):4946-57.
9
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.与流感病毒肽复合的人类II类主要组织相容性复合体蛋白HLA-DR1的晶体结构。
Nature. 1994 Mar 17;368(6468):215-21. doi: 10.1038/368215a0.
10
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.肽与HLA DRB1*0101和DRB1*0401结合的需求探索。
J Immunol. 1994 Mar 15;152(6):2890-8.